Health technology assessment in clinical biochemistry. Methylmalonic acid: A Danish showcase

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 63, Issue 5, 2003, Pages 319-328

  Hvas, A M ^a   Ellegaard, J ^a   Lous, J ^b   Nexo E ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Diagnostic test; Laboratory test; Vitamin B 12; Vitamin B 12 deficiency

Indexed keywords

COBALAMIN DERIVATIVE; CYANOCOBALAMIN; METHYLMALONIC ACID;

ARTICLE; BIOCHEMISTRY; CLINICAL ARTICLE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; CYANOCOBALAMIN DEFICIENCY; DENMARK; DIAGNOSTIC TEST; ECONOMIC ASPECT; HEALTH; HUMAN; MEASUREMENT; MEDICAL ASSESSMENT; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; TECHNOLOGY; VITAMIN BLOOD LEVEL;

EID: 0142030132     PISSN: 00365513     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365510310002013     Document Type: Article

References (30)

1. Allen RH, Stabler SP, Savage DG, Lindenbaum J. Metabolic abnormalities in cobalamin (vitamin B12) and folate deficiency. FASEB J 1993; 7: 1344-53.
2. Savage DG, Lindenbaum J, Stabler SP, Allen RH. Sensitivity of serum methylmalonic acid and total homocysteine determinations for diagnosing cobalamin and folate deficiencies. Am J Med 1994; 96: 239-46.
3. Lindenbaum J, Savage DG, Stabler SP, Allen RH. Diagnosis of cobalamin deficiency: II. Relative sensitivities of serum cobalamin, methylmalonic acid, and total homocysteine concentrations. Am J Hematol 1990; 34: 99-107.
4. Rasmussen K. Solid-phase sample extraction for rapid determination of methylmalonic acid in serum and urine by a stable-isotope-dilution method. Clin Chem 1989; 35: 260-4.
5. Lindenbaum J, Healton EB, Savage DG, Brust JC, Garrett TJ, Podell ER, et al. Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis. N Engl J Med 1988; 318: 1720-8.
6. Pennypacker LC, Allen RH, Kelly JP, Matthews LM, Grigsby J, Kaye K, et al. High prevalence of cobalamin deficiency in elderly outpatients. J Am Geriatr Soc 1992; 40: 1197-204.
7. Carmel R, Gott PS, Waters CH, Cairo K, Green R, Bondareff W, ???. The frequently low cobalamin levels in dementia usually signify treatable metabolic, neurologic and electrophysiologic abnormalities. Eur J Haematol 1995; 54: 245-53.
8. Stabler SP, Allen RH, Savage DG, Lindenbaum J. Clinical spectrum and diagnosis of cobalamin deficiency. Blood 1990; 76: 871-81.
9. Lindenbaum J, Rosenberg IH, Wilson PW, Stabler SP, Allen RH. Prevalence of cobalamin deficiency in the Framingham elderly population. Am J Clin Nutr 1994; 60: 2-11.
10. Joosten E, van den Berg A, Riezler R, Naurath HJ, Lindenbaum J, Stabler SP, et al. Metabolic evidence that deficiencies of vitamin B-12 (cobalamin), folate, and vitamin B-6 occur commonly in elderly people. Am J Clin Nutr 1993; 58: 468-76.
11. Kristensen MO, Gulmann NC, Christensen JE, Ostergaard K, Rasmussen K. Serum cobalamin and methylmalonic acid in Alzheimer dementia. Acta Neurol Scand 1993; 87: 475-81.
12. England JM, Linnell JC. Problems with the serum vitamin B12 assay. Lancet 1980; ii: 1072-3.
13. Herbert V, Colman N, Palat D, Manusselis C, Drivas G, Block E, et al. Is there a "gold standard" for human serum vitamin B12 assay? J Lab Clin Med 1984; 104: 829-41.
14. Rasmussen K, Vyberg B, Pedersen KO, Brochner-Mortensen J. Methylmalonic acid in renal insufficiency: evidence of accumulation and implications for diagnosis of cobalamin deficiency. Clin Chem 1990; 36: 1523-4.
15. Hvas AM, Juul S, Gerdes LU, Nexø E. The marker of cobalamin deficiency, plasma methylmalonic acid, correlates to plasma creatinine. J Intern Med 2000; 247: 507-12.
16. Hvas AM, Vestergaard H, Gerdes LU, Nexø E. Physicians' use of plasma methylmalonic acid as a diagnostic tool. J Intern Med 2000; 247: 311-7.
17. Hvas AM, Lous J, Ellegaard J, Nexø E. Use of plasma methylmalonic acid in diagnosing vitamin B-12 deficiency in general practice. Scand J Prim Health Care 2002; 20: 57-9.
18. Hølleland G, Schneede J, Ueland PM, Lund PK, Refsum H, Sandberg S. Cobalamin deficiency in general practice. Assessment of the diagnostic utility and cost-benefit analysis of methylmalonic acid determination in relation to current diagnostic strategies. Clin Chem 1999; 45: 189-98.
19. Bolann BJ, Solli JD, Schneede J. Grottum KA, Loraas A, Stokkeland M, et al. Evaluation of indicators of cobalamin deficiency defined as cobalamin-induced reduction in increased serum methylmalonic acid. Clin Chem 2000; 46: 1744-50.
20. Nexø E, Hansen M, Rasmussen K, Lindgren A, Grasbeck R. How to diagnose cobalamin deficiency. Scand J Clin Lab Invest 1994: Suppl. 219: 61-76.
21. Hvas AM, Ellegaard J, Nexø E. Increased plasma methylmalonic acid does not predict clinical manifestations of vitamin B-12 deficiency. Arch Intern Med 2001; 161: 1534-41.
22. Hvas AM, Ellegaard J, Nexø E. Vitamin B-12 treatment normalizes metabolic markers but has limited clinical effect: A randomized placebo-controlled study. Clin Chem 2001; 47: 1396-404.
23. Møller-Petersen J. Evaluation of diagnostic tests. Design and phases. Scand J Clin Lab Invest 1992; Suppl. 208: 35-50.
24. Rasmussen K, Moller J, Ostergaard K, Kristensen MO, Jensen J. Methylmalonic acid concentrations in serum of normal subjects: biological variability and effect of oral L-isoleucine loads before and after intramuscular administration of cobalamin. Clin Chem 1990; 36: 1295-9.
25. Rasmussen K. P-methylmalonate and P-homocysteine: metabolic markers of vitamin deficiencies. Background, validity and applications. Ugeskr Laeger 1996; 158: 3913-8.
26. Lijmer JG, Mol BW, Heisterkamp S, Bonsel GJ, Prins MH, van der Meulen JH, et al. Empirical evidence of design-related bias in studies of diagnostic tests. JAMA 1999; 282: 1061-6.
27. Stabler SP, Marcell PD, Podell ER, Allen RH, Lindenbaum J. Assay of methylmalonic acid in the serum of patients with cobalamin deficiency using capillary gas chromatography-mass spectrometry. J Clin Invest 1986; 77: 1606-12.
28. Moelby L, Nielsen G, Rasmussen K, Jensen MK, Pedersen KO. Metabolic cobalamin deficiency in patients with low to low-normal plasma cobalamins. Scand J Clin Lab Invest 1997; 57: 209-16.
29. Kwok T, Tang C, Woo J, Lai WK, Law LK, Pang CP. A randomized trial of the effect of supplementation on the cognitive function of older people with subnormal cobalamin levels. Int J Geriat Psychiatry 1998; 13: 611-6.
30. Eccles M, Freemantle N, Mason J. North of England evidence-based guidelines development project. Br Med J 1998; 316: 1232-5.